Business Update21 Dec 2023, 06:41 pm
Venus Remedies Achieves Marketing Authorizations in Israel and Colombia
AI Summary
Venus Remedies, a global leader in pharmaceutical innovation, has secured marketing authorizations for three variants of Docetaxel in Israel and Cytarabine in Colombia, further solidifying its commitment to advancing healthcare solutions globally.,
Key Highlights
- Secured marketing authorizations for three variants of Docetaxel in Israel and Cytarabine in Colombia
- Global leader in pharmaceutical innovation
- Commitment to advancing healthcare solutions globally